# AbbVie (prior sponsor, Abbott) clinical trials: 223 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 223 trials with AbbVie (prior sponsor, Abbott) as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by AbbVie (prior sponsor, Abbott): 223 rows for $11.15, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/abbvie-prior-sponsor-abbott

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 223
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 223, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| February 4, 2013 | NCT01782469 | Rheumatoid Arthritis Patients on Adalimumab to Evaluate Its Effect on Synovitis Using Ultrasonography in an Egyptian Population | AbbVie (prior sponsor, Abbott) | Observational | Terminated | Rheumatoid Arthritis | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01782469) |
| January 23, 2013 | NCT01773070 | A Follow up Study Designed to Obtain Long Term Data on Participants Who Either Achieved a Sustained Virologic Response or Did Not Achieve a... | AbbVie (prior sponsor, Abbott) | Phase 3 | Completed | Hepatitis C | 478 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01773070) |
| January 14, 2013 | NCT01767116 | A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1b Infection | AbbVie (prior sponsor, Abbott) | Phase 3 | Completed | Chronic Hepatitis C Infection | 419 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01767116) |
| January 3, 2013 | NCT01759264 | An Observational Study of Fecal Calprotectin as Clinical Tool in Monitoring Moderate-to-severe Crohn's Disease on Adalimumab Induction... | AbbVie (prior sponsor, Abbott) | Observational | Completed | Crohn's Disease | 101 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01759264) |
| January 1, 2013 | NCT01758705 | Post Marketing Observational Study on Venezuelan Patients With Psoriasis | AbbVie (prior sponsor, Abbott) | Observational | Withdrawn | Moderate to Severe Chronic Plaque Psoriasis | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01758705) |
| January 1, 2013 | NCT01758289 | Post Marketing Observational Study on Paricalcitol IV Administered to Venezuelan Patients | AbbVie (prior sponsor, Abbott) | Observational | Terminated | Chronic Kidney Disease Stage V, Hemodialysis | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01758289) |
| December 25, 2012 | NCT01756235 | Physical Activity in Patients With Rheumatoid Arthritis Treated With Adalimumab in Routine Clinical Practice | AbbVie (prior sponsor, Abbott) | Observational | Completed | Rheumatoid Arthritis | 462 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01756235) |
| December 21, 2012 | NCT01754727 | Impact of Adalimumab (Humira®) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis... | AbbVie (prior sponsor, Abbott) | Observational | Completed | Ankylosing Spondylitis | 452 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01754727) |
| December 21, 2012 | NCT01754129 | Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa | AbbVie (prior sponsor, Abbott) | Observational | Completed | Parkinson's Disease | 148 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01754129) |
| December 19, 2012 | NCT01752855 | Study in Rheumatoid Arthritis for Subjects Who Completed Preceding Study M13-390 With Adalimumab | AbbVie (prior sponsor, Abbott) | Phase 2 | Completed | Rheumatoid Arthritis | 88 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01752855) |
| December 17, 2012 | NCT01749631 | Investigation of the Effectiveness of Sevoflurane Anaesthesia in Difficult to Intubate Egyptian Patients | AbbVie (prior sponsor, Abbott) | Observational | Completed | Intubation; Difficult | 97 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01749631) |
| December 12, 2012 | NCT01747655 | A Post Marketing Observational Study of Activities of Daily Living in Advanced Parkinson's Disease Patients With Early Troublesome Motor... | AbbVie (prior sponsor, Abbott) | Observational | Completed | Parkinson's Disease | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01747655) |
| December 5, 2012 | NCT01741727 | A Study of ABT-414 in Subjects With Solid Tumors | AbbVie (prior sponsor, Abbott) | Phase 1 | Completed | Squamous Cell Tumors | 57 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01741727) |
| December 5, 2012 | NCT01741493 | A Study in Healthy Adults and Adult Subjects With Rheumatoid Arthritis to Evaluate the Safety, Tolerability and Pharmacokinetics After... | AbbVie (prior sponsor, Abbott) | Phase 1 | Completed | Rheumatoid Arthritis | 67 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01741493) |
| December 4, 2012 | NCT01741142 | Efficacy and Safety Study of ABT-436 in Major Depressive Disorder | AbbVie (prior sponsor, Abbott) | Phase 2 | Terminated | Major Depressive Disorder | 19 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01741142) |
| November 29, 2012 | NCT01736189 | Assessment of Clinical Effectiveness and Safety of Adalimumab and High Dose Methotrexate in Routine Clinical Practice | AbbVie (prior sponsor, Abbott) | Observational | Completed | Rheumatoid Arthritis | 346 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01736189) |
| November 29, 2012 | NCT01736176 | A Study to Assess the Safety and Efficacy of Levodopa-carbidopa Intestinal Gel (LCIG) for the Treatment of Non-motor Symptoms in Patients... | AbbVie (prior sponsor, Abbott) | Phase 3 | Completed | Advanced Parkinson's Disease | 39 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01736176) |
| October 30, 2012 | NCT01716585 | A Study to Evaluate Chronic Hepatitis C Infection | AbbVie (prior sponsor, Abbott) | Phase 3 | Completed | Chronic Hepatitis C Infection | 636 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01716585) |
| October 29, 2012 | NCT01715857 | Clinical Practice of Inhalation Anesthesia With Sevoflurane in China | AbbVie (prior sponsor, Abbott) | Observational | Completed | Anesthesia, General | 4,100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01715857) |
| October 29, 2012 | NCT01715415 | A Study to Evaluate Chronic Hepatitis C Infection in Treatment Experienced Adults | AbbVie (prior sponsor, Abbott) | Phase 3 | Completed | Chronic Hepatitis C Infection | 395 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01715415) |
| October 23, 2012 | NCT01712178 | A Study in Rheumatoid Arthritis (RA) Patients to Compare Two Formulations of Adalimumab for Pharmacokinetic, Pharmacodynamic and Safety | AbbVie (prior sponsor, Abbott) | Phase 2 | Completed | Rheumatoid Arthritis | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01712178) |
| October 11, 2012 | NCT01704755 | A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as... | AbbVie (prior sponsor, Abbott) | Phase 3 | Completed | Chronic Hepatitis C Infection, Compensated Cirrhosis | 381 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01704755) |
| September 21, 2012 | NCT01690195 | Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease | AbbVie (prior sponsor, Abbott) | Phase 2 | Terminated | Alzheimer's Disease | 343 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01690195) |
| September 18, 2012 | NCT01686555 | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE) | AbbVie (prior sponsor, Abbott) | Phase 1 | Completed | Lupus Erythematosus | 97 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01686555) |
| September 14, 2012 | NCT01685203 | A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic... | AbbVie (prior sponsor, Abbott) | Phase 2 | Completed | Hepatitis C, Chronic | 316 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01685203) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 22 |
| Phase 1/2 | 4 |
| Phase 2 | 67 |
| Phase 3 | 45 |
| Phase 4 | 9 |
| Observational | 76 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 213 |
| Terminated | 9 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Arthritis, Rheumatoid | 32 |
| Hepatitis C | 17 |
| Psoriasis | 16 |
| Renal Insufficiency, Chronic | 14 |
| Hyperparathyroidism, Secondary | 12 |
| Spondylitis, Ankylosing | 10 |
| Hepatitis C, Chronic | 9 |
| Arthritis, Psoriatic | 9 |
| Crohn Disease | 9 |
| Pain | 8 |
| Alzheimer Disease | 7 |
| Acquired Immunodeficiency Syndrome | 7 |
| Infections | 6 |
| Neoplasm Metastasis | 5 |
| Dyskinesias | 5 |
| Arthritis | 5 |
| Kidney Failure, Chronic | 5 |
| Attention Deficit Disorder with Hyperactivity | 5 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Parkinson Disease | 4 |
| Respiratory Syncytial Virus Infections | 4 |
| Diabetic Nephropathies | 4 |
| Hidradenitis Suppurativa | 3 |
| Acne Vulgaris | 3 |
| Colitis, Ulcerative | 3 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Janitorial companies in the United States](https://specstream.ai/data/businesses/janitorial-companies/united-states)
- [Tiling contractors in the United States](https://specstream.ai/data/businesses/tiling-contractors/united-states)
- [Diners in the United States](https://specstream.ai/data/businesses/diners/united-states)
- [Optometrists in the United States](https://specstream.ai/data/businesses/optometrists/united-states)
- [Apparel manufacturers in the United States](https://specstream.ai/data/businesses/apparel-manufacturers/united-states)
- [Furniture manufacturers in the United States](https://specstream.ai/data/businesses/furniture-manufacturers/united-states)
